Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page for NCT03077828. The title, objectives, eligibility criteria, and locations appear unchanged.
    Difference
    0.3%
    Check dated 2025-10-30T15:22:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Major update: page version bumped to v3.2.0 and a government funding operating-status notice added; previous v3.0.2 revision removed.
    Difference
    3%
    Check dated 2025-10-02T01:25:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Update tags indicate the page now reflects version v3.1.0 instead of v3.0.2. No other content changes are shown.
    Difference
    0.1%
    Check dated 2025-09-30T13:59:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. This is a minor housekeeping update with no impact on core content, pricing, stock, or timing.
    Difference
    0.2%
    Check dated 2025-09-16T05:21:01.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-09T01:03:31.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with additional drug information and publications related to a clinical trial. Some previously listed locations and drug information have been removed.
    Difference
    8%
    Check dated 2025-09-01T21:03:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.